Schedule 13G ownership disclosure

CIDARA THERAPEUTICS INC

Common Stock, $0.0001 par value per share · CUSIP: 171757206

Event date: 2025-12-31

Filing-level shares
0
Percent of class
0%
  • BCLS Fund III Investments, LP

    Shares: 0 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-054780
Form type
SCHEDULE 13G/A
Filer
BCLS Fund III Investments, LP
CIK
CIK 1952107
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub